SCHEMBL1010767

SCHEMBL1010767

CC(C(=O)O)c1cnc(Cc2ccc(NC(=O)Oc3ccccc3)cc2)nc1N(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPT P10636 2/20 0.48
KDM4E B2RXH2 1/20 0.48
THRB P10828 1/20 0.48
GFER P55789 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.43
FAAH O00519 6/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
MAPKAPK2 P49137 1/20 0.40
RAD51 Q06609 1/20 0.40
PTGS2 P35354 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1010687 0.88 ROCK2 (0.46) MAPTTP53RAB9AMAPKAPK2
SCHEMBL27634908 0.84 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL3443471 0.83 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL12569081 0.83 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL1010750 0.82 NR1H4 (0.50) MEN1KMT2AKDM4ERAB9A
SCHEMBL1011783 0.82 KMT2A (0.47) MEN1KMT2A
SCHEMBL1009771 0.78 CPB2 (0.36) LMNAADRB3PTGS2
SCHEMBL27655918 0.73 POLB (0.43) KMT2AMAPTTP53GAARAB9A
SCHEMBL27634906 0.72 POLB (0.45) ALDH1A1MAPTTP53RAB9AMAPKAPK2
SCHEMBL983506 0.72 ALDH1A1 (0.68) ALDH1A1MEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960393-B2 Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 ACTIMIS PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
EP-1633726-B1 PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES MEDIATED BY CRTH2 ACTIMIS PHARMACEUTICALS INC (US) 2011-01-05 EP disclosed